Clinical Trial Update: Research on Cognitive Effect of Cannabidiol on Dravet Syndrome and Lennox-Gastaut SyndromeGastaut Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial update investigating the cognitive effects of cannabidiol in Dravet Syndrome and Lennox-Gastaut Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome
• Lennox-gastaut Syndrome

Drugs mentioned

• Cannabidiol (cannabidiol)

Snippet

Sponsor: Yonsei University | Conditions: Dravet Syndrome, Lennox Gastaut Syndrome | Phase 3 | Status: UNKNOWN